speb/financial-data huggingface dataset:
Financial ratios for AZO — annual report dated 2022-08-31
Total revenue: 16252230000
Gross profit: 8472650000
Operating income: 3270729000
Net income: 2429604000
Capital expenditures: 57987000
Operating cash flow: 3211135000
Depreciation & amortization: 442223000
Net tangible assets: -3841558000
Owner earnings: 2813840000
Return on net tangible assets (%): -73.24736474107641
Capex to operating income (%): 1.7729075077757894
Buffett classification: The Great
Stock price: 2119.21
P/E ratio: 14.239709668550926
Shares outstanding: 16325355
Book value: -3538913000
Market cap (USD): 34596855569.55
Debt to equity: -2.6268939078185873
Current ratio: 0.7717373902195672
Quick ratio: 0.11526952713971053
Effective tax rate (%): 21.093465571494963
Interest coverage ratio: 16.54507147698876
COGS to revenue (%): 47.8677695307044
SG&A to revenue (%): 32.007429134340335
Free cash flow (dilution-adjusted): 2468132000
Buyback yield (%): 12.602275346194736
Retained earnings: -1330067000
Inventory turnover: 1.3798464846779108
Receivables turnover: 32.18990029432387
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 48.914314342757585
FCF margin (%): 15.186420571207767
Rule of 40 score: 15.186420571207767
Financial ratios for AZO — annual report dated 2023-08-31
Total revenue: 17457209000
Gross profit: 9070422000
Operating income: 3473986000
Net income: 2528426000
Capital expenditures: 27042000
Operating cash flow: 2940788000
Depreciation & amortization: 497577000
Net tangible assets: -4652539000
Owner earnings: 2998961000
Return on net tangible assets (%): -64.45858917034333
Capex to operating income (%): 0.7784141905004798
Buffett classification: The Great
Stock price: 2531.33
P/E ratio: 16.34410533357512
Shares outstanding: 16325355
Book value: -4349894000
Market cap (USD): 41324860872.15
Debt to equity: -2.5126513427683523
Current ratio: 0.7964685962732452
Quick ratio: 0.11927868610559202
Effective tax rate (%): 20.178847548975348
Interest coverage ratio: 10.909869168974895
COGS to revenue (%): 48.04196936635174
SG&A to revenue (%): 32.058022562484076
Free cash flow (dilution-adjusted): 2051044000
Buyback yield (%): 8.952364077995561
Retained earnings: -2959278000
Inventory turnover: 1.454992875783963
Receivables turnover: 33.54671829510843
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 46.48081046590444
FCF margin (%): 11.748980034551915
Revenue growth (%): 7.414237923041946
Rule of 40 score: 19.16321795759386
Financial ratios for AZO — quarterly report dated 2024-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3181.48
Shares outstanding: 16325355
Market cap (USD): 51938790425.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZO — annual report dated 2024-08-31
Total revenue: 18490268000
Gross profit: 9817052000
Operating income: 3788708000
Net income: 2662427000
Capital expenditures: 1072696000
Operating cash flow: 3004116000
Depreciation & amortization: 549755000
Net tangible assets: -5052259000
Owner earnings: 2139486000
Return on net tangible assets (%): -42.34711640871935
Capex to operating income (%): 28.312976349721332
Buffett classification: The Good
Stock price: 3181.48
P/E ratio: 19.508061789262204
Shares outstanding: 16325355
Book value: -4749614000
Market cap (USD): 51938790425.4
Debt to equity: -2.6037840127639846
Current ratio: 0.8384846509329611
Quick ratio: 0.13214469690597336
Effective tax rate (%): 20.218061627805927
Interest coverage ratio: 8.18489922011709
COGS to revenue (%): 46.9069242263011
SG&A to revenue (%): 32.60279407524001
Free cash flow (dilution-adjusted): 1825174000
Buyback yield (%): 6.047343371446661
Retained earnings: -4424982000
Inventory turnover: 1.4090834800652066
Receivables turnover: 33.891340329010674
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 44.771637008636546
FCF margin (%): 9.870998083965036
Revenue growth (%): 5.917664158113705
Rule of 40 score: 15.78866224207874
Financial ratios for AZO — quarterly report dated 2024-11-30
Capital expenditures: 12001000
Depreciation & amortization: 133173000
Buffett classification: The Gruesome
Stock price: 3169.54
Shares outstanding: 16325355
Market cap (USD): 51743865686.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AZO — quarterly report dated 2025-02-28
Total revenue: 3952012000
Gross profit: 2128401000
Operating income: 706767000
Net income: 487923000
Capital expenditures: 292702000
Operating cash flow: 583749000
Depreciation & amortization: 137918000
Net tangible assets: -4760418000
Owner earnings: 333139000
Return on net tangible assets (%): -6.9981039480146485
Capex to operating income (%): 41.414214302591944
Buffett classification: The Good
Stock price: 3493.01
P/E ratio: 29.218046837590155
Shares outstanding: 16325355
Book value: -4457773000
Market cap (USD): 57024628268.55
Debt to equity: -2.7739723400002645
Current ratio: 0.8419442565987261
Quick ratio: 0.1309987302744461
Effective tax rate (%): 18.40002006873542
Interest coverage ratio: 6.4947069526382535
COGS to revenue (%): 46.143862923493145
SG&A to revenue (%): 35.97241101494631
Free cash flow (dilution-adjusted): 260601000
Buyback yield (%): 0.5723737443107745
Retained earnings: -5421243000
Inventory turnover: 0.2767833644426892
Receivables turnover: 6.615308903187793
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.98704068133949
FCF margin (%): 6.5941348356229685
Rule of 40 score: 6.5941348356229685
Financial ratios for AZO — quarterly report dated 2025-05-31
Total revenue: 4464339000
Gross profit: 2353523000
Operating income: 866174000
Net income: 608440000
Capital expenditures: 345886000
Operating cash flow: 769030000
Depreciation & amortization: 144696000
Net tangible assets: -4277050000
Owner earnings: 407250000
Return on net tangible assets (%): -9.521749804187465
Capex to operating income (%): 39.932623237363394
Buffett classification: The Good
Stock price: 3733.04
P/E ratio: 55.58670187629462
Shares outstanding: 16325355
Book value: -3974405000
Market cap (USD): 60943203229.2
Debt to equity: -3.0667969167711897
Current ratio: 0.8436618743684324
Quick ratio: 0.12284884055682009
Effective tax rate (%): 19.400070738876842
Interest coverage ratio: 7.783385002471133
COGS to revenue (%): 47.28171404546116
SG&A to revenue (%): 33.316219937598824
Free cash flow (dilution-adjusted): 394123000
Buyback yield (%): 0.44103359481967336
Retained earnings: -4812803000
Inventory turnover: 0.3093731225856057
Receivables turnover: 7.585782156414291
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.45971625678429
FCF margin (%): 8.828249826010076
Revenue growth (%): 12.963700515079408
Rule of 40 score: 21.791950341089482
Financial ratios for AZO — quarterly report dated 2025-08-31
Total revenue: 6242726000
Gross profit: 3216493000
Operating income: 1196066000
Net income: 836950000
Capital expenditures: 441634000
Operating cash flow: 952755000
Depreciation & amortization: 197412000
Net tangible assets: -3716958000
Owner earnings: 592728000
Return on net tangible assets (%): -15.946588581307616
Capex to operating income (%): 36.92388212690604
Buffett classification: The Good
Stock price: 4198.53
P/E ratio: 35.45338635189956
Shares outstanding: 16325355
Book value: -3414313000
Market cap (USD): 68542492728.149994
Debt to equity: -3.5992001904922013
Current ratio: 0.8762507751278784
Quick ratio: 0.13821159050305393
Effective tax rate (%): 20.136682258597034
Interest coverage ratio: 7.5195900917892615
COGS to revenue (%): 48.476146478317325
SG&A to revenue (%): 32.36449909863095
Free cash flow (dilution-adjusted): 471988000
Buyback yield (%): 0.6462064368693333
Retained earnings: -3975852000
Inventory turnover: 0.4307383134576998
Receivables turnover: 9.315596661578155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.160175649941282
FCF margin (%): 7.560607337243377
Revenue growth (%): 39.835393324745276
Rule of 40 score: 47.39600066198865
Financial ratios for AZO — annual report dated 2025-08-31
Total revenue: 18938717000
Gross profit: 9966474000
Operating income: 3610156000
Net income: 2498247000
Capital expenditures: 1327257000
Operating cash flow: 3117337000
Depreciation & amortization: 613199000
Net tangible assets: -3716958000
Owner earnings: 1784189000
Return on net tangible assets (%): -48.00132258691113
Capex to operating income (%): 36.764533166987796
Buffett classification: The Good
Stock price: 4198.53
P/E ratio: 27.436235379508112
Shares outstanding: 16325355
Book value: -3414313000
Market cap (USD): 68542492728.149994
Debt to equity: -3.5992001904922013
Current ratio: 0.8762507751278784
Quick ratio: 0.13821159050305393
Effective tax rate (%): 20.294116896359416
Interest coverage ratio: 7.416157897764156
COGS to revenue (%): 47.37513634107316
SG&A to revenue (%): 33.56255864639616
Free cash flow (dilution-adjusted): 1665363000
Buyback yield (%): 2.302492858348947
Retained earnings: -3975852000
Inventory turnover: 1.2770625453336386
Receivables turnover: 28.260963056807785
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 36.70376976160966
FCF margin (%): 8.79343093832597
Revenue growth (%): 2.425324500434499
Rule of 40 score: 11.21875543876047
Financial ratios for AZO — quarterly report dated 2025-11-30
Total revenue: 4628630000
Gross profit: 2359313000
Operating income: 784205000
Net income: 530823000
Capital expenditures: 1091000
Operating cash flow: 944171000
Depreciation & amortization: 148194000
Net tangible assets: -3531252000
Owner earnings: 677926000
Return on net tangible assets (%): -19.197893551635513
Capex to operating income (%): 0.13912178575755063
Buffett classification: The Great
Stock price: 3954.33
P/E ratio: 26.19816480792862
Shares outstanding: 16325355
Book value: -3228607000
Market cap (USD): 64555841037.15
Debt to equity: -3.73213060617164
Current ratio: 0.860257772265434
Quick ratio: 0.13227722949838464
Effective tax rate (%): 21.70001548821052
Interest coverage ratio: 7.379363884445281
COGS to revenue (%): 49.027833289763926
Free cash flow (dilution-adjusted): 598180000
Buyback yield (%): 0.6617185883368346
Retained earnings: -3445029000
Inventory turnover: 0.3176378602793003
Receivables turnover: 7.256737201707641
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.960137848975771
FCF margin (%): 12.923478437464217
Revenue growth (%): -25.8556278138749
Rule of 40 score: -12.932149376410683
Financial ratios for AZO — quarterly report dated 2026-02-28
Total revenue: 4274098000
Gross profit: 2243358000
Operating income: 698456000
Net income: 468860000
Capital expenditures: 336713000
Operating cash flow: 373429000
Depreciation & amortization: 155640000
Net tangible assets: -3211415000
Owner earnings: 287787000
Return on net tangible assets (%): -8.961376838558705
Capex to operating income (%): 48.20819063763501
Buffett classification: The Good
Stock price: 3755.58
P/E ratio: 25.075397229816858
Shares outstanding: 16325355
Book value: -2908770000
Market cap (USD): 61311176730.9
Debt to equity: -4.266847155326822
Current ratio: 0.8902220829469975
Quick ratio: 0.1358738451375302
Effective tax rate (%): 20.700345538527632
Interest coverage ratio: 6.515143883214402
COGS to revenue (%): 47.51271496348469
Free cash flow (dilution-adjusted): -26000
Buyback yield (%): 0.5129831407092994
Retained earnings: -4391569000
Inventory turnover: 0.27134267819448366
Receivables turnover: 6.120052808229378
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.640961941895862
FCF margin (%): -0.0006083154855129668
Revenue growth (%): -7.659545048966973
Rule of 40 score: -7.660153364452486
Financial ratios for BB1.AX — annual report dated 2024-06-30
Operating income: -1190466
Net income: -1168846.6666666667
Capital expenditures: 20818.666666666668
Depreciation & amortization: 54407.333333333336
Net tangible assets: 4087360.6666666665
Owner earnings: -1135258.0000000002
Return on net tangible assets (%): -27.77484280401975
Buffett classification: The Gruesome
Stock price: 0.17333333333333334
Shares outstanding: 153257474
Book value: 4322677.333333333
P/B ratio: 6.145410998368913
Market cap (USD): 26564628.826666668
Debt to equity: 0.026015512608235394
Current ratio: 23.01119081988248
Quick ratio: 23.01119081988248
Interest coverage ratio: -394.02007943512797
Free cash flow (dilution-adjusted): -1264553.3333333333
Buyback yield (%): 1.2443514098774315
Retained earnings: -1943198
Capitalized R&D asset: 120083.33333333333
ROCI (R&D-adjusted, %): -24.581141156741186
Rule of 40 score: 0
Financial ratios for BLSE.NS — annual report dated 2024-03-31
Total revenue: 36152932.006235756
Gross profit: 7984938.241995443
Operating income: 4633661.110444898
Net income: 4021813.1670464086
Capital expenditures: 556697.4457368989
Operating cash flow: 2356529.5598992687
Depreciation & amortization: 404029.26010312984
Net tangible assets: 41925686.53315745
Owner earnings: 3869144.98141264
Return on net tangible assets (%): 9.228578709981715
Capex to operating income (%): 12.014202861793835
Buffett classification: The Great
Stock price: 3.6867802303262955
P/E ratio: 83.10223399251731
Shares outstanding: 90654077
Book value: 52495598.992684975
P/B ratio: 6.366660544794431
Market cap (USD): 334221658.88207775
Debt to equity: 0.01669450530974907
Current ratio: 4.68513838602289
Quick ratio: 4.660898051174883
Effective tax rate (%): 26.62238354348126
Interest coverage ratio: 48.59778644195699
COGS to revenue (%): 77.91344215009124
SG&A to revenue (%): 1.1699974094407146
Free cash flow (dilution-adjusted): 1799832.1141623696
Buyback yield (%): 0
Retained earnings: 6747283.846984051
Inventory turnover: 147.16678152997935
Receivables turnover: 52.71262217404227
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.70623713304173
FCF margin (%): 4.978384917306097
Revenue growth (%): 22.11582200297931
Rule of 40 score: 27.09420692028541
Financial ratios for BLSE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 44869565.217391305
Buffett classification: The Gruesome
Stock price: 2.660176779741997
Shares outstanding: 90654077
Book value: 55539811.27568084
P/B ratio: 4.342036191432608
Market cap (USD): 241155870.62434304
Debt to equity: 0.013548560118697758
Current ratio: 5.095388199424322
Quick ratio: 5.063428935391169
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLSE.NS — quarterly report dated 2025-03-31
Total revenue: 27964203.881225158
Gross profit: 3119698.386719663
Operating income: 2050514.3792377834
Net income: 2023696.5162497077
Capital expenditures: 0
Depreciation & amortization: 219534.72059855037
Net tangible assets: 40566682.25391629
Owner earnings: 2243231.236848258
Return on net tangible assets (%): 5.529737982532938
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.724588633446143
P/E ratio: 19.313789087738417
Shares outstanding: 90654077
Book value: 60589583.82043488
P/B ratio: 2.5803278535975473
Market cap (USD): 156340990.76975143
Debt to equity: 0.013754253706418864
Current ratio: 2.056864342852072
Quick ratio: 2.0535928228256095
Effective tax rate (%): 25.802594018156412
Interest coverage ratio: 84.28688130706391
COGS to revenue (%): 88.84395779700994
Buyback yield (%): 0
Retained earnings: 12658954.874912322
Inventory turnover: 436.74455404849977
Receivables turnover: 6.313514340990132
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.349707465641822
Rule of 40 score: 0
Financial ratios for BLSE.NS — annual report dated 2025-03-31
Total revenue: 60714671.498714045
Gross profit: 9461982.69815291
Operating income: 6339852.700490998
Net income: 6875379.939209726
Capital expenditures: 1531458.9665653494
Operating cash flow: 7866401.683422959
Depreciation & amortization: 727846.6214636427
Net tangible assets: 40566682.25391629
Owner earnings: 6071767.594108019
Return on net tangible assets (%): 14.967375335511576
Capex to operating income (%): 24.156065431090276
Buffett classification: The Great
Stock price: 1.724588633446143
P/E ratio: 22.73925108896915
Shares outstanding: 90654077
Book value: 60589583.82043488
P/B ratio: 2.5803278535975473
Market cap (USD): 156340990.76975143
Debt to equity: 0.013754253706418864
Current ratio: 2.056864342852072
Quick ratio: 2.0535928228256095
Effective tax rate (%): 25.681712206815416
Interest coverage ratio: 72.22146757224664
COGS to revenue (%): 84.41565693334384
SG&A to revenue (%): 1.1903842721322844
Free cash flow (dilution-adjusted): 6334942.71685761
Buyback yield (%): 0
Retained earnings: 12658954.874912322
Inventory turnover: 900.9771886559803
Receivables turnover: 13.707629612620387
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.35674372095759
FCF margin (%): 10.433956999984405
Revenue growth (%): 67.93844407485904
Rule of 40 score: 78.37240107484344
Financial ratios for BLSE.NS — quarterly report dated 2025-06-30
Total revenue: 28549953.19447695
Gross profit: 2620582.7287619943
Operating income: 1913994.8513924645
Net income: 2050292.5345190733
Capital expenditures: 0
Depreciation & amortization: 160484.4371635853
Owner earnings: 2210776.9716826584
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.336297683126609
P/E ratio: 25.824962352355353
Shares outstanding: 90654077
Market cap (USD): 211794910.06108123
Effective tax rate (%): 24.999357937180573
Interest coverage ratio: 93.1492027334852
COGS to revenue (%): 90.8210612083632
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.094639689152956
Rule of 40 score: 2.094639689152956
Financial ratios for BLSE.NS — quarterly report dated 2025-09-30
Total revenue: 30411961.66854566
Gross profit: 2665016.9109357386
Operating income: 2084047.3506200677
Net income: 2060890.6426155579
Capital expenditures: 0
Depreciation & amortization: 170541.1499436302
Net tangible assets: 38059436.302142054
Owner earnings: 2231431.792559188
Return on net tangible assets (%): 5.863018503071205
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.0591882750845545
P/E ratio: 30.428275985316475
Shares outstanding: 90654077
Book value: 61535467.86922209
P/B ratio: 3.0335970280382014
Market cap (USD): 186673812.4470124
Debt to equity: 0.013614754765127527
Current ratio: 3.0216684887232703
Quick ratio: 3.0158455539907263
Effective tax rate (%): 25.67070840144104
Interest coverage ratio: 98.85294117647058
COGS to revenue (%): 91.23694505477395
Buyback yield (%): 0
Inventory turnover: 255.14762595894672
Receivables turnover: 2.354670381708308
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.352284669365953
Revenue growth (%): 6.521931792269692
Rule of 40 score: 6.521931792269692
Financial ratios for BLSE.NS — quarterly report dated 2025-12-31
Total revenue: 31266169.098808065
Gross profit: 2462403.9211317813
Operating income: 1681252.0886710484
Net income: 1695956.3328506183
Capital expenditures: 0
Depreciation & amortization: 175815.9741561769
Owner earnings: 1871772.3070067952
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.2553191489361706
P/E ratio: 26.108818407417846
Shares outstanding: 90654077
Market cap (USD): 204453875.78723407
Effective tax rate (%): 27.332693748776915
Interest coverage ratio: 90.86453943407587
COGS to revenue (%): 92.12438238483892
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.808787672338451
Rule of 40 score: 2.808787672338451
Financial ratios for CD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.52
Shares outstanding: 79443800
Market cap (USD): 279642176
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CD — annual report dated 2022-12-31
Total revenue: 863438
Gross profit: -517162
Operating income: -2711363
Net income: -5634971
Capital expenditures: 7222
Operating cash flow: -1551357
Depreciation & amortization: 28950
Net tangible assets: 12595636
Owner earnings: -5613243
Return on net tangible assets (%): -44.56498266542476
Buffett classification: The Gruesome
Stock price: 1.24
Shares outstanding: 79443800
Book value: 16828864
P/B ratio: 5.853651916136466
Market cap (USD): 98510312
Debt to equity: 0.05372507615487296
Current ratio: 5.257170953746815
Quick ratio: 5.257170953746815
COGS to revenue (%): 159.89567287981302
SG&A to revenue (%): 253.76031631686354
Free cash flow (dilution-adjusted): -2116974
Buyback yield (%): 0
Retained earnings: -667320289
Receivables turnover: 24.03446068197634
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.526044559336679
FCF margin (%): -245.1796191504196
Rule of 40 score: -245.1796191504196
Financial ratios for CD — annual report dated 2023-12-31
Total revenue: 445928
Gross profit: -978384
Operating income: -3943575
Net income: -9357196
Capital expenditures: 3003808
Operating cash flow: -2789415
Depreciation & amortization: 898968
Net tangible assets: 17127458
Owner earnings: -11462036
Return on net tangible assets (%): -66.92199157633316
Buffett classification: The Gruesome
Stock price: 2.6
Shares outstanding: 79443800
Book value: 17832767
P/B ratio: 11.582828396737309
Market cap (USD): 206553880
Debt to equity: 0.5402670825004331
Current ratio: 1.9296092292483198
Quick ratio: 1.9296092292483198
Interest coverage ratio: -20.114636199025785
COGS to revenue (%): 319.4040293500296
SG&A to revenue (%): 664.9483773165175
Free cash flow (dilution-adjusted): -5870723
Buyback yield (%): 0
Retained earnings: -676677485
Receivables turnover: 0.08554819347142709
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.769610742363003
FCF margin (%): -1316.518137457168
Revenue growth (%): -48.35436939305428
Rule of 40 score: -1364.8725068502222
Financial ratios for CD — annual report dated 2024-12-31
Total revenue: 494025
Gross profit: 234432
Operating income: -1964123
Net income: -4534397
Capital expenditures: 1997389
Operating cash flow: -3574217
Depreciation & amortization: 2509
Net tangible assets: 23968818
Owner earnings: -6529277
Return on net tangible assets (%): -27.2407133301275
Buffett classification: The Gruesome
Stock price: 6.83
Shares outstanding: 79443800
Book value: 24088818
P/B ratio: 22.525021941715863
Market cap (USD): 542601154
Debt to equity: 0.32306603835854464
Current ratio: 2.606941604234841
Quick ratio: 2.606941604234841
COGS to revenue (%): 52.5465310459997
R&D to revenue (%): 0
SG&A to revenue (%): 442.71099640706444
Free cash flow (dilution-adjusted): -3576828
Buyback yield (%): 0
Retained earnings: -680448810
Receivables turnover: 0.1510794139027006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.14515026073216
FCF margin (%): -724.0176104448155
Revenue growth (%): 10.785821926409644
Rule of 40 score: -713.2317885184059
Financial ratios for CD — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 23968818
Buffett classification: The Gruesome
Stock price: 6.83
Shares outstanding: 79443800
Book value: 24088818
P/B ratio: 22.525021941715863
Market cap (USD): 542601154
Debt to equity: 0.32306603835854464
Current ratio: 2.606941604234841
Quick ratio: 2.606941604234841
Buyback yield (%): 0
Retained earnings: -680448810
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CD — quarterly report dated 2025-03-31
Total revenue: 25065
Gross profit: -42347
Operating income: -784835
Net income: -1301478
Capital expenditures: 0
Operating cash flow: -800059
Depreciation & amortization: 126550
Owner earnings: -1174928
Buffett classification: The Gruesome
Stock price: 5.36
Shares outstanding: 79443800
Market cap (USD): 425818768
COGS to revenue (%): 268.94873329343704
R&D to revenue (%): 0
SG&A to revenue (%): 2962.2501496110112
Free cash flow (dilution-adjusted): -917388
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): -3660.0359066427286
Rule of 40 score: -3660.0359066427286
Financial ratios for CD — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 28649035
Buffett classification: The Gruesome
Stock price: 7.19
Shares outstanding: 79443800
Book value: 30550621
P/B ratio: 18.696867798530185
Market cap (USD): 571200922
Debt to equity: 0.11973390000812095
Current ratio: 5.269539323778349
Quick ratio: 5.269539323778349
Buyback yield (%): 0
Retained earnings: -682143714
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CD — quarterly report dated 2025-06-30
Total revenue: 441512
Gross profit: -146849
Operating income: -1887318
Net income: -1687114
Capital expenditures: 0
Operating cash flow: -528879
Depreciation & amortization: 126551
Net tangible assets: 27758410
Owner earnings: -1560563
Return on net tangible assets (%): -5.621946646079513
Buffett classification: The Gruesome
Stock price: 3.85
Shares outstanding: 79443800
Book value: 29423200
P/B ratio: 10.395151784985996
Market cap (USD): 305858630
Debt to equity: 0.1221824274721988
Current ratio: 4.5542604526956545
Quick ratio: 4.5542604526956545
COGS to revenue (%): 133.26047763141207
SG&A to revenue (%): 246.26850459330663
Free cash flow (dilution-adjusted): -778372
Buyback yield (%): 0
Retained earnings: -683437402
Receivables turnover: 0.08752056132160187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.408898276307032
FCF margin (%): -176.29690699233544
Rule of 40 score: -176.29690699233544
Financial ratios for CD — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 43912194
Buffett classification: The Gruesome
Stock price: 4.97
Shares outstanding: 79443800
Book value: 44032194
P/B ratio: 8.966977343895241
Market cap (USD): 394835686
Debt to equity: 0.02387117026237666
Current ratio: 25.712863871568448
Quick ratio: 25.712863871568448
Buyback yield (%): 0
Retained earnings: -685546641
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CD — annual report dated 2025-12-31
Total revenue: 1867068
Gross profit: 1200710
Operating income: -3674436
Net income: -5097831
Capital expenditures: 1000000
Operating cash flow: -2409623
Depreciation & amortization: 2592
Net tangible assets: 43912194
Owner earnings: -6095239
Return on net tangible assets (%): -13.880515740115376
Buffett classification: The Gruesome
Stock price: 4.97
Shares outstanding: 79443800
Book value: 44032194
P/B ratio: 8.966977343895241
Market cap (USD): 394835686
Debt to equity: 0.02387117026237666
Current ratio: 25.712863871568448
Quick ratio: 25.712863871568448
COGS to revenue (%): 35.690076633523795
R&D to revenue (%): 7.890499971077647
SG&A to revenue (%): 250.71481060143498
Free cash flow (dilution-adjusted): -4171341
Buyback yield (%): 0
Retained earnings: -685546641
Receivables turnover: 0.7210343589129654
Capitalized R&D asset: 147321
ROCI (R&D-adjusted, %): -7.949753739653458
FCF margin (%): -223.41666184627448
Revenue growth (%): 277.9298618490967
Rule of 40 score: 54.51320000282223
Financial ratios for CENTENKA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.75972570222867
Shares outstanding: 21850589
Market cap (USD): 147703988.07213506
Buyback yield (%): 0
Retained earnings: 104136885.13780826
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CENTENKA.NS — annual report dated 2023-03-31
Total revenue: 250573690.62119368
Gross profit: 42902557.85627284
Operating income: 12421437.271619977
Net income: 11001218.02679659
Capital expenditures: 28684531.059683315
Operating cash flow: 26707673.568818517
Depreciation & amortization: 5020706.455542022
Net tangible assets: 160875761.2667479
Owner earnings: -12662606.577344703
Return on net tangible assets (%): -7.8710468734620935
Capex to operating income (%): 230.92763286919
Buffett classification: The Gruesome
Stock price: 3.9584652862362977
P/E ratio: 7.862292868810895
Shares outstanding: 21850589
Book value: 160987819.73203412
P/B ratio: 0.5372754173842976
Market cap (USD): 86494798.0403167
Debt to equity: 0.05132744701939155
Current ratio: 5.430368016944665
Quick ratio: 3.819565792957374
Effective tax rate (%): 23.249490142760028
Interest coverage ratio: 50.99
COGS to revenue (%): 82.87826716766882
SG&A to revenue (%): 0.966843443304281
Free cash flow (dilution-adjusted): -2390986.6017052378
Buyback yield (%): 0
Retained earnings: 104485992.69183923
Inventory turnover: 7.005999342537804
Receivables turnover: 9.478483228897899
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.9302018987040706
FCF margin (%): -0.9542049669212186
Rule of 40 score: -0.9542049669212186
Financial ratios for CENTENKA.NS — annual report dated 2024-03-31
Total revenue: 207984170.76388055
Gross profit: 36717831.87432546
Operating income: 4036455.210456889
Net income: 5126513.97050006
Capital expenditures: 12108166.446816165
Operating cash flow: 10560019.186952872
Depreciation & amortization: 6027101.570931766
Net tangible assets: 163575968.34152776
Owner earnings: -954550.9053843394
Return on net tangible assets (%): -0.5835520431652571
Capex to operating income (%): 299.9702911467617
Buffett classification: The Gruesome
Stock price: 4.663387715930902
P/E ratio: 19.87661965125112
Shares outstanding: 21850589
Book value: 163614342.24727187
P/B ratio: 0.6227923966131029
Market cap (USD): 101897768.3284549
Debt to equity: 0.03829578269983436
Current ratio: 4.566084358119756
Quick ratio: 3.019020802206643
Effective tax rate (%): 25.6909438553798
Interest coverage ratio: 6.473076923076923
COGS to revenue (%): 82.34585269664088
SG&A to revenue (%): 1.081654539374301
Free cash flow (dilution-adjusted): -3231802.374385418
Buyback yield (%): 0
Retained earnings: 105383139.4651637
Inventory turnover: 5.304917911002154
Receivables turnover: 8.804406315041373
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.228799586817902
FCF margin (%): -1.5538693942503952
Revenue growth (%): -16.996804314024374
Rule of 40 score: -18.55067370827477
Financial ratios for CENTENKA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 166895604.3956044
Buffett classification: The Gruesome
Stock price: 7.89787386526517
Shares outstanding: 21850589
Book value: 166926660.29622552
P/B ratio: 1.0338264450837562
Market cap (USD): 172573195.8037506
Debt to equity: 0.03715179140041932
Current ratio: 3.0165839033074113
Quick ratio: 1.9135513288984667
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CENTENKA.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.125305979717915
Shares outstanding: 21850589
Market cap (USD): 155692132.46205848
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CENTENKA.NS — quarterly report dated 2025-03-31
Total revenue: 51905541.26724339
Gross profit: 12486555.997194294
Operating income: -565817.1615618424
Net income: 790273.556231003
Capital expenditures: 0
Depreciation & amortization: 1591068.505962123
Net tangible assets: 165692073.88356322
Owner earnings: 2381342.062193126
Return on net tangible assets (%): 1.4372094007746963
Buffett classification: The Gruesome
Stock price: 6.1971058466565525
P/E ratio: 42.83656329416894
Shares outstanding: 21850589
Book value: 165717792.84545243
P/B ratio: 0.8171145084648358
Market cap (USD): 135410412.84478936
Debt to equity: 0.025974392437656514
Current ratio: 4.061401919942039
Quick ratio: 2.6340789712008688
Effective tax rate (%): 27.233584499461788
Interest coverage ratio: -4.989690721649485
COGS to revenue (%): 75.94369369369369
Buyback yield (%): 0
Retained earnings: 107891045.12508766
Inventory turnover: 1.069731290250944
Receivables turnover: 2.5362732777333488
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.310077519379845
Rule of 40 score: 0
Financial ratios for CENTENKA.NS — annual report dated 2025-03-31
Total revenue: 234006312.83610004
Gross profit: 53252279.635258354
Operating income: 6989712.41524433
Net income: 7770633.621697451
Capital expenditures: 5451250.876782792
Operating cash flow: 13779518.353986438
Depreciation & amortization: 6426233.341126958
Net tangible assets: 165692073.88356322
Owner earnings: 8745616.086041616
Return on net tangible assets (%): 5.278234426703731
Capex to operating income (%): 77.98963037297207
Buffett classification: The Gruesome
Stock price: 6.1971058466565525
P/E ratio: 17.425916525866228
Shares outstanding: 21850589
Book value: 165717792.84545243
P/B ratio: 0.8171145084648358
Market cap (USD): 135410412.84478936
Debt to equity: 0.025974392437656514
Current ratio: 4.061401919942039
Quick ratio: 2.6340789712008688
Effective tax rate (%): 27.702849684576897
Interest coverage ratio: 13.169603524229075
COGS to revenue (%): 77.24322947109692
SG&A to revenue (%): 1.0905784612002858
Free cash flow (dilution-adjusted): 7767126.490530745
Buyback yield (%): 0
Retained earnings: 107891045.12508766
Inventory turnover: 4.905206053107452
Receivables turnover: 11.434308237175825
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.830482413991928
FCF margin (%): 3.31919527998841
Revenue growth (%): 12.51159738582308
Rule of 40 score: 15.83079266581149
Financial ratios for CENTENKA.NS — quarterly report dated 2025-06-30
Total revenue: 46984554.17739294
Gross profit: 11002808.331383104
Operating income: 723145.3311490756
Net income: 1799672.361338638
Capital expenditures: 0
Depreciation & amortization: 1604259.3025977067
Owner earnings: 3403931.663936345
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.789492160074889
P/E ratio: 48.84419124366409
Shares outstanding: 21850589
Market cap (USD): 126503813.70851862
Effective tax rate (%): 19.22268907563025
Interest coverage ratio: 7.7250000000000005
COGS to revenue (%): 76.5820735686001
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -9.480658460941621
Rule of 40 score: -9.480658460941621
Financial ratios for CENTENKA.NS — quarterly report dated 2025-09-30
Total revenue: 46076662.908680946
Gross profit: 18163472.37880496
Operating income: 2039458.8500563698
Net income: 2517474.6335963923
Capital expenditures: 0
Depreciation & amortization: 1526493.7993235625
Net tangible assets: 161862457.72266066
Owner earnings: 4043968.432919955
Return on net tangible assets (%): 2.498398016326303
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.414881623449831
P/E ratio: 23.165970307779475
Shares outstanding: 21850589
Book value: 161883878.24126267
P/B ratio: 0.7308841011414364
Market cap (USD): 118318352.83765501
Debt to equity: 0.02534977818944084
Current ratio: 5.251983400463811
Quick ratio: 3.629317710240449
Effective tax rate (%): 12.190326386158082
Interest coverage ratio: 24.12
COGS to revenue (%): 60.57988744800588
Buyback yield (%): 0
Inventory turnover: 0.9311745458648314
Receivables turnover: 2.6400103352496607
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1411809235427708
Revenue growth (%): -1.9323185770459688
Rule of 40 score: -1.9323185770459688
Financial ratios for CENTENKA.NS — quarterly report dated 2025-12-31
Total revenue: 45856076.640303
Gross profit: 18988526.233708367
Operating income: 3038877.1304444694
Net income: 2643422.0786454272
Capital expenditures: 0
Depreciation & amortization: 1511640.859975493
Owner earnings: 4155062.9386209203
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.91311128439345
P/E ratio: 13.850671535199883
Shares outstanding: 21850589
Market cap (USD): 107354375.3865434
Effective tax rate (%): 25
Interest coverage ratio: 35.89473684210526
COGS to revenue (%): 58.59103607433499
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.4787375093008002
Rule of 40 score: -0.4787375093008002
Financial ratios for CPZ — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.62
Shares outstanding: 19632194
Market cap (USD): 247758288.27999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPZ — annual report dated 2022-10-31
Total revenue: -41927809
Net income: -42753217
Capital expenditures: 0
Operating cash flow: -9161829
Net tangible assets: 346747424
Owner earnings: -42753217
Return on net tangible assets (%): -12.329786478817503
Buffett classification: The Gruesome
Stock price: 10.47
Shares outstanding: 19632194
Book value: 346747424
P/B ratio: 0.5927919198615301
Market cap (USD): 205549071.18
Debt to equity: 0.34607322706455057
Free cash flow (dilution-adjusted): -9161829
Buyback yield (%): 0
Retained earnings: -45880833
Receivables turnover: -0.41624852914276667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPZ — annual report dated 2023-10-31
Total revenue: 11595843
Net income: 11011730
Capital expenditures: 0
Operating cash flow: 119549418
Net tangible assets: 324777068
Owner earnings: 11011730
Return on net tangible assets (%): 3.390550345137053
Buffett classification: The Gruesome
Stock price: 10.17
P/E ratio: 18.131520930861907
Shares outstanding: 19632194
Book value: 324777068
P/B ratio: 0.6147583454999354
Market cap (USD): 199659412.98
Debt to equity: 0.3694842149384759
COGS to revenue (%): 0
SG&A to revenue (%): 4.7103604283017635
Free cash flow (dilution-adjusted): 119549418
Buyback yield (%): 0
Retained earnings: -67851157
Receivables turnover: 0.4914587125226401
Capitalized R&D asset: 0
FCF margin (%): 1030.9678908208743
Rule of 40 score: 1030.9678908208743
Financial ratios for CPZ — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 344209921
Buffett classification: The Gruesome
Stock price: 12.71
Shares outstanding: 19632194
Book value: 344209921
P/B ratio: 0.7249215392022359
Market cap (USD): 249525185.74
Debt to equity: 0.3486244662889888
Buyback yield (%): 0
Retained earnings: -48418262
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPZ — annual report dated 2024-10-31
Total revenue: 53069555
Net income: 52414939
Capital expenditures: 0
Operating cash flow: 60426377
Net tangible assets: 344209921
Owner earnings: 52414939
Return on net tangible assets (%): 15.227608445370755
Buffett classification: The Gruesome
Stock price: 12.71
P/E ratio: 4.760573807784075
Shares outstanding: 19632194
Book value: 344209921
P/B ratio: 0.7249215392022359
Market cap (USD): 249525185.74
Debt to equity: 0.3486244662889888
COGS to revenue (%): 0
SG&A to revenue (%): 1.0265151083328286
Free cash flow (dilution-adjusted): 60426377
Buyback yield (%): 0
Retained earnings: -48418262
Receivables turnover: 20.005894003685306
Capitalized R&D asset: 0
FCF margin (%): 113.86260352098299
Revenue growth (%): 357.6601718391669
Rule of 40 score: 471.52277536014986
Financial ratios for CPZ — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 330753263
Buffett classification: The Gruesome
Stock price: 13.37
Shares outstanding: 19632194
Book value: 330753263
P/B ratio: 0.7935898542594272
Market cap (USD): 262482433.77999997
Debt to equity: 0.3628082121142974
Buyback yield (%): 0
Retained earnings: -61874920
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVNA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.36
Shares outstanding: 716288385
Market cap (USD): 33207129528.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVNA — annual report dated 2022-12-31
Total revenue: 13604000000
Gross profit: 1246000000
Operating income: -1504000000
Net income: -1587000000
Capital expenditures: 468000000
Operating cash flow: -1324000000
Depreciation & amortization: 261000000
Net tangible assets: -588000000
Owner earnings: -1794000000
Buffett classification: The Gruesome
Stock price: 0.95
Shares outstanding: 716288385
Book value: -1053000000
Market cap (USD): 680473965.75
Debt to equity: -8.372269705603038
Current ratio: 1.7723765432098766
Quick ratio: 1.0486111111111112
Interest coverage ratio: -3.094650205761317
COGS to revenue (%): 90.84092913848868
SG&A to revenue (%): 20.11173184357542
Free cash flow (dilution-adjusted): -1905000000
Buyback yield (%): 0
Retained earnings: -2076000000
Inventory turnover: 6.587420042643923
Receivables turnover: 53.77075098814229
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -24.6315099901736
FCF margin (%): -14.00323434284034
Rule of 40 score: -14.00323434284034
Financial ratios for CVNA — annual report dated 2023-12-31
Total revenue: 10771000000
Gross profit: 1724000000
Operating income: -80000000
Net income: 450000000
Capital expenditures: 15000000
Operating cash flow: 803000000
Depreciation & amortization: 352000000
Net tangible assets: 191000000
Owner earnings: 787000000
Return on net tangible assets (%): 412.04188481675396
Buffett classification: The Gruesome
Stock price: 10.59
P/E ratio: 16.856653327
Shares outstanding: 716288385
Book value: -384000000
Market cap (USD): 7585493997.15
Debt to equity: -17.463541666666668
Current ratio: 2.162109375
Quick ratio: 1.4134114583333333
Effective tax rate (%): 14.285714285714285
Interest coverage ratio: -0.12658227848101267
COGS to revenue (%): 83.99405811902331
SG&A to revenue (%): 16.674403490855074
Free cash flow (dilution-adjusted): 643000000
Buyback yield (%): 0
Retained earnings: -1626000000
Inventory turnover: 7.86695652173913
Receivables turnover: 40.49248120300752
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4453477868112015
FCF margin (%): 5.969733543774951
Revenue growth (%): -20.824757424286975
Rule of 40 score: -14.855023880512025
Financial ratios for CVNA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 34.82
Shares outstanding: 716288385
Market cap (USD): 24941161565.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVNA — annual report dated 2024-12-31
Total revenue: 13673000000
Gross profit: 2876000000
Operating income: 990000000
Net income: 404000000
Capital expenditures: 80000000
Operating cash flow: 918000000
Depreciation & amortization: 305000000
Net tangible assets: 1226000000
Owner earnings: 629000000
Return on net tangible assets (%): 51.305057096247964
Capex to operating income (%): 8.080808080808081
Buffett classification: The Great
Stock price: 40.67
P/E ratio: 72.10754608403465
Shares outstanding: 716288385
Book value: 1375000000
P/B ratio: 21.186508085781817
Market cap (USD): 29131448617.95
Debt to equity: 4.397090909090909
Current ratio: 3.6390134529147984
Quick ratio: 2.437219730941704
Effective tax rate (%): -1
Interest coverage ratio: 1.5207373271889402
COGS to revenue (%): 78.96584509617495
SG&A to revenue (%): 13.705843633438164
Free cash flow (dilution-adjusted): 736000000
Buyback yield (%): 0
Retained earnings: -1416000000
Inventory turnover: 6.71455223880597
Receivables turnover: 44.53745928338762
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.85390428211587
FCF margin (%): 5.382871352300154
Revenue growth (%): 26.942716553709033
Rule of 40 score: 32.32558790600919
Financial ratios for CVNA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40.67
Shares outstanding: 716288385
Market cap (USD): 29131448617.95
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVNA — quarterly report dated 2025-03-31
Total revenue: 4232000000
Gross profit: 929000000
Operating income: 394000000
Net income: 373000000
Capital expenditures: 26000000
Operating cash flow: 232000000
Depreciation & amortization: 73000000
Net tangible assets: 1467000000
Owner earnings: 420000000
Return on net tangible assets (%): 28.629856850715747
Capex to operating income (%): 6.598984771573605
Buffett classification: The Great
Stock price: 41.82
P/E ratio: 20.077198566152816
Shares outstanding: 716288385
Book value: 1773000000
P/B ratio: 16.89519473248731
Market cap (USD): 29955180260.7
Debt to equity: 3.4083474337281445
Current ratio: 3.81365998515219
Quick ratio: 2.6978470675575354
Effective tax rate (%): 0.5333333333333333
Interest coverage ratio: 2.8345323741007196
COGS to revenue (%): 78.04820415879017
SG&A to revenue (%): 12.641776937618149
Free cash flow (dilution-adjusted): 182000000
Buyback yield (%): 0
Retained earnings: -1200000000
Inventory turnover: 2.197604790419162
Receivables turnover: 11.345844504021448
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.231708936396229
FCF margin (%): 4.300567107750473
Rule of 40 score: 4.300567107750473
Financial ratios for CVNA — quarterly report dated 2025-06-30
Total revenue: 4840000000
Gross profit: 1064000000
Operating income: 511000000
Net income: 308000000
Capital expenditures: 31000000
Operating cash flow: 29000000
Depreciation & amortization: 68000000
Net tangible assets: 1696000000
Owner earnings: 345000000
Return on net tangible assets (%): 20.34198113207547
Capex to operating income (%): 6.066536203522505
Buffett classification: The Great
Stock price: 67.39
P/E ratio: 70.88204737907489
Shares outstanding: 716288385
Book value: 2117000000
P/B ratio: 22.801452180042514
Market cap (USD): 48270674265.15
Debt to equity: 2.8856872933396316
Current ratio: 4.003528581510233
Quick ratio: 2.575864502470007
Effective tax rate (%): 0
Interest coverage ratio: 3.5734265734265733
COGS to revenue (%): 78.01652892561984
SG&A to revenue (%): 11.384297520661157
Free cash flow (dilution-adjusted): -29000000
Buyback yield (%): 0
Retained earnings: -1017000000
Inventory turnover: 1.8665348492338112
Receivables turnover: 14.892307692307693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.428481570008807
FCF margin (%): -0.5991735537190083
Revenue growth (%): 14.366729678638942
Rule of 40 score: 13.767556124919933
Financial ratios for CVNA — quarterly report dated 2025-09-30
Total revenue: 5647000000
Gross profit: 1148000000
Operating income: 552000000
Net income: 263000000
Capital expenditures: 37000000
Operating cash flow: 345000000
Depreciation & amortization: 65000000
Net tangible assets: 2241000000
Owner earnings: 291000000
Return on net tangible assets (%): 12.985274431057563
Capex to operating income (%): 6.702898550724639
Buffett classification: The Great
Stock price: 75.45
P/E ratio: 57.24995619518009
Shares outstanding: 716288385
Book value: 2951000000
P/B ratio: 18.31377792214504
Market cap (USD): 54043958648.25
Debt to equity: 1.899356150457472
Current ratio: 4.047157622739018
Quick ratio: 2.551033591731266
Effective tax rate (%): -1.5444015444015444
Interest coverage ratio: 4.416
COGS to revenue (%): 79.67062156897468
SG&A to revenue (%): 10.53656808925093
Free cash flow (dilution-adjusted): 283000000
Buyback yield (%): 0
Retained earnings: -866000000
Inventory turnover: 1.942573402417962
Receivables turnover: 15.817927170868348
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.646598434677905
FCF margin (%): 5.01151053656809
Revenue growth (%): 16.673553719008265
Rule of 40 score: 21.685064255576354
Financial ratios for CVNA — annual report dated 2025-12-31
Total revenue: 20322000000
Gross profit: 4192000000
Operating income: 1881000000
Net income: 1895000000
Capital expenditures: 145000000
Operating cash flow: 1036000000
Depreciation & amortization: 275000000
Net tangible assets: 3384000000
Owner earnings: 2025000000
Return on net tangible assets (%): 59.840425531914896
Capex to operating income (%): 7.708665603402445
Buffett classification: The Great
Stock price: 84.4
P/E ratio: 31.902237305540897
Shares outstanding: 716288385
Book value: 4203000000
P/B ratio: 14.383711561741615
Market cap (USD): 60454739694.00001
Debt to equity: 1.3135855341422793
Current ratio: 4.311389071757735
Quick ratio: 2.726135615536537
Interest coverage ratio: 3.724752475247525
COGS to revenue (%): 79.3721090443854
SG&A to revenue (%): 11.357149886822162
Free cash flow (dilution-adjusted): 793000000
Buyback yield (%): 0
Retained earnings: -9000000
Inventory turnover: 6.6985049833887045
Receivables turnover: 81.288
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.101694915254235
FCF margin (%): 3.902174982777286
Revenue growth (%): 48.62868426826593
Rule of 40 score: 52.53085925104321